32 reports

  • HEALTHCARE PROVIDERS IN NORWAY
  • HEALTHCARE PROVIDERS IN SWEDEN

Primary Health Care Ltd (PHC) is one of Australia' s leading listed healthcare companies.

  • Healthcare
  • Scandinavia
  • Market Size
  • Fortis Inc.
  • Netcare Limited
  • HEALTHCARE PROVIDERS IN SWEDEN
  • HEALTHCARE PROVIDERS IN NORWAY

TABLE ##: HCA HEALTHCARE, INC. : KEY FACTS HCA operates in one segment: operating hospitals and related health care entities.

  • Health Care Provider
  • Health Services
  • Healthcare
  • Northern Europe
  • Scandinavia
  • The Scandinavian Healthcare and Therapy Dog Association
  • Scandinavia pet healthcare market geography segmentation: $ million, 2017

MARKET DATA MARKET VALUE Table ##: Scandinavia pet healthcare market value: $ million, 2013-## Figure ##: Scandinavia pet healthcare market value: $ million, 2013-## The Scandinavian pet healthcare market grew by ##. ##% in 2017 to reach a volume of ##. ## milli

  • Healthcare
  • Scandinavia
  • Bayer AG
  • Eli Lilly & Co.
  • Orion Corporation
  • Scandinavia healthcare providers sector geography segmentation: % share, by value, 2016
  • Factors influencing the threat of substitutes in the healthcare providers sector in Scandinavia, 2016

MARKET DATA MARKET VALUE Table ##: Scandinavia healthcare providers sector value: $ billion, 2012-## Figure ##: Scandinavia healthcare providers sector value: $ billion, 2012-## MARKET SEGMENTATION CATEGORY SEGMENTATION Outpatient care is the largest segment of the

  • Health Care Provider
  • Healthcare
  • Scandinavia
  • Market Size
  • Falck Danmark A/S
  • NORWAY: SELF-MONITORING OF BLOOD GLUCOSE (SMBG) MARKET (MILLION US$), 2010 - 2017
  • 11.3 BLOOD GLUCOSE DEVICES (SMBG) MARKET AND FORECAST

FIGURE ##-##: WORLDWIDE: HEALTHCARE SPENDING ON DIABETES (BILLION US$), 2010 & 2030 Most countries aspire to deliver effective, safe, and affordable healthcare to their citizens.

  • Healthcare
  • Scandinavia
  • Forecast
  • Abbott Laboratories, Inc.
  • Roche Group
  • MARKET ANALYSIS
  • MARKET DEFINITION

LEADING COMPANIES Table ##: Novartis AG: key facts NOVARTIS AG Novartis AG (Novartis or ' the company' ) is one of the largest providers of healthcare products worldwide.

  • Healthcare
  • Scandinavia
  • F. Hoffmann-La Roche Ltd.
  • Novartis AG
  • Pfizer Inc.
  • NORWAY: SELF-MONITORING OF BLOOD GLUCOSE (SMBG) MARKET (MILLION US$), 2008 - 2016
  • 12.3 NORWAY SELF-MONITORING OF BLOOD GLUCOSE (SMBG) MARKET AND

FIGURE ##-##: WORLDWIDE: HEALTHCARE SPENDING ON DIABETES (BILLION US$), 2010 AND 2030 CAPITA HEALTHCARE EXPENDING Most countries aspire to deliver effective, safe, and affordable healthcare to their citizens.

  • Healthcare
  • Scandinavia
  • Forecast
  • Bayer AG
  • Roche Group
  • Norway: Self-Monitoring of Blood Glucose (SMBG) Market (Million US$), 2010 - 2017
  • 10.3 Blood Glucose Devices (SMBG) Market and Forecast

Figure ##-##: Worldwide: Healthcare Spending on Diabetes (Billion US$), 2010 & 2030 Most countries aspire to deliver effective, safe, and affordable healthcare to their citizens.

  • Diabetes
  • Diabetes Monitoring
  • Healthcare
  • Scandinavia
  • Forecast
  • INITIATIVES TAKEN IN COMMUNICATION, EDUCATION, TRAINING & INFORMATION EXCHANGE RELATED TO SEASONAL INFLUENZA IN EUROPEAN COUNTRIES, 2009

Sweden ##.

  • Healthcare
  • Scandinavia
  • MedImmune, LLC
  • Novartis AG
  • Sanofi S.A.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system.

  • Healthcare
  • Scandinavia
  • Demand
  • Market Size
  • Supply
  • SWEDEN: SELF-MONITORING OF BLOOD GLUCOSE (SMBG) MARKET (MILLION US$), 2007 - 2015
  • 11.3 NORWAY SELF-MONITORING OF BLOOD GLUCOSE (SMBG) MARKET AND

CAPITA HEALTHCARE EXPENDING FIGURE ##-##: WORLDWIDE: HEALTHCARE SPENDING ON DIABETES (BILLION US$), 2010 & 2030 TABLE ##-##: WORLDWIDE: PER CAPITA HEALTHCARE SPENDING (US$), 2005 - 2012 Most countries aspire to deliver effective, safe, and affordable

  • Healthcare
  • Scandinavia
  • Forecast
  • LifeScan, Inc.
  • Roche Group
  • SWEDEN: SELF-MONITORING OF BLOOD GLUCOSE (SMBG) MARKET (MILLION US$), 2007 - 2015
  • 12.3 NORWAY SELF-MONITORING OF BLOOD GLUCOSE (SMBG) MARKET AND

CAPITA HEALTHCARE EXPENDING FIGURE ##-##: WORLDWIDE: HEALTHCARE SPENDING ON DIABETES (BILLION US$), 2010 AND 2030 MOST COUNTRIES ASPIRE TO DELIVER EFFECTIVE, SAFE, AND AFFORDABLE HEALTHCARE TO THEIR CITIZENS.

  • Healthcare
  • Scandinavia
  • Forecast
  • Bayer AG
  • Roche Group
  • Sweden - Cervical Cancer Test Market (Million US$), 2008 - 2015
  • We have taken screening population between the age group 25-59 years for cervical cancer test market

Reduction of health care costs is one of the priorities for NHS in UK in consideration of tight government budgets.

  • Healthcare
  • Scandinavia
  • World
  • Demographic
  • Forecast
  • 10.3 Norway Self-Monitoring of Blood Glucose (SMBG) Market and
  • NORWAY: SELF-MONITORING OF BLOOD GLUCOSE (SMBG) MARKET (MILLION US$), 2007 - 2015

TABLE ##-##: WORLDWIDE: PER CAPITA HEALTHCARE SPENDING (US$), 2005 - 2012 ##.

  • Diabetes Monitoring
  • Healthcare
  • Northern Europe
  • Scandinavia
  • Forecast

The driving force behind the need for rapid reporting of microbiological test results is the clinical relevance in a time of financial austerity, a time when cost and health care effectiveness to the patient and diagnostician looms ever larger, and where after-the-fact results at high expen

  • Healthcare
  • Infectious Disease
  • Pathology
  • Northern Europe
  • Scandinavia
  • Larix A/S, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018

GlobalData Deal Value (US$ million) NA NA NA Deal Type Asset Purchases Licensing Agreement Partnerships Larix A/ S, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 No. of Deals ## ## ## Larix A/ S, Pharmaceuticals & Healthcare, D

  • Drug Development
  • Healthcare
  • Scandinavia
  • United States
  • Deals & Alliance
  • University of Gothenburg, Pharmaceuticals & Healthcare, Deal Details
  • University of Gothenburg, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018

GlobalData Therapy Area Infectious Disease Gastrointestinal Metabolic Disorders No. of Deals ## ## ## Deal Value (US$ million) ##. ## NA NA University of Gothenburg, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 University of Gothenburg, Pharmaceuti

  • Chronic Disease
  • Healthcare
  • Pharmaceutical
  • Scandinavia
  • Sweden

GlobalData Therapy Area Central Nervous System Dermatology Infectious Disease Oncology No. of Deals ## ## ## ## Deal Value (US$ million) NA NA NA NA DESITIN ARZNEIMITTEL GMBH, PHARMACEUTICALS & HEALTHCARE, DEALS SUMMARY, 2012 TO YTD 2018 DESITIN ARZNEIMITTEL GMBH,

  • Healthcare
  • Pharmaceutical
  • Scandinavia
  • Deals & Alliance
  • Desitin Arzneimittel GmbH

The driving force behind the need for rapid reporting of microbiological test results is the clinical relevance in a time of financial austerity, a time when cost and health care effectiveness to the patient and diagnostician looms ever larger, and where after-the-fact results at high expen

  • Healthcare
  • Infectious Disease
  • Pathology
  • Australasia
  • Scandinavia
  • Scandinavian Biopharma Holding AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • Scandinavian Biopharma Holding AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018

GlobalData Scandinavian Biopharma Holding AB' s, deal volume increased from zero pharmaceuticals & healthcare deals in 2016 to one pharmaceuticals & healthcare deal in 2017.

  • Biopharmaceutical
  • Healthcare
  • Scandinavia
  • Deals & Alliance
  • Scandinavian Biopharma Holding

The driving force behind the need for rapid reporting of microbiological test results is the clinical relevance in a time of financial austerity, a time when cost and health care effectiveness to the patient and diagnostician looms ever larger, and where after-the-fact results at high expen

  • Healthcare
  • Infectious Disease
  • Pathology
  • Northern Europe
  • Scandinavia

The driving force behind the need for rapid reporting of microbiological test results is the clinical relevance in a time of financial austerity, a time when cost and health care effectiveness to the patient and diagnostician looms ever larger, and where after-the-fact results at high expen

  • Healthcare
  • Infectious Disease
  • Pathology
  • Northern Europe
  • Scandinavia

And, in the current healthcare reform debate, the future of new technologies remains unclear.

  • Healthcare
  • Scandinavia
  • World
  • Market Size
  • Varian Medical Systems, Inc.

One unit consists of pneumatic compression pump and sleeve.

  • Healthcare
  • Wound Care
  • Scandinavia
  • Demand
  • Market Size
  • Sophion Bioscience A/S, Pharmaceuticals & Healthcare, Deal Details

GlobalData Sophion Bioscience A/ S, reported one pharmaceuticals & healthcare deal worth $##. ## million in YTD 2017.

  • Healthcare
  • Denmark
  • Scandinavia
  • Deals & Alliance
  • M&A

The health care costs of diabetic peripheral neuropathy in the US.

  • Chronic Disease
  • Healthcare
  • Pathology
  • Type 2 Diabetes
  • Scandinavia
  • Sweden - Cervical Cancer Test Market (Million US$), 2008 - 2015
  • We have taken screening population between the age group 25-59 years for cervical cancer test market

Reduction of health care costs is one of the priorities for NHS in UK in consideration of tight government budgets.

  • Cancer Diagnostics
  • Diagnostics
  • Healthcare
  • Scandinavia
  • Forecast

The driving force behind the need for rapid reporting of microbiological test results is the clinical relevance in a time of financial austerity, a time when cost and health care effectiveness to the patient and diagnostician looms ever larger, and where after-the-fact results at high expen

  • Healthcare
  • Infectious Disease
  • Pathology
  • Northern Europe
  • Scandinavia

GlobalData offers comprehensive geographic coverage across world' s most important sectors, focusing particularly on energy and healthcare.

  • Healthcare
  • Medical Device
  • Scandinavia
  • Demand
  • Enzymatica

One subscription right entitles the shareholders to subscribe for one new share.

  • Healthcare
  • Medical Device
  • Medical Equipment
  • Scandinavia
  • Deals & Alliance